STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8
Clinical trials for STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early trial is testing whether the drug olaparib can shrink tumors in people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. Fifteen participants will receive olaparib for two cycles, then undergo standard chemotherapy…
Matched conditions: STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control OngoingThis trial investigates a new type of immunotherapy for people with advanced cancers that carry a specific marker called NY-ESO-1. Researchers take a patient's own T cells, modify them in the lab to better recognize and attack cancer cells, and then infuse them back. The study al…
Matched conditions: STAGE IIIA FALLOPIAN TUBE CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC